The cross-industry collaboration platform Pharma.Aero has just published the White Paper of the Cell and Gene Therapies Project that explores the CGT fast-developing sector and the particularities that have an impact on its logistics. The project’s main goal was to broaden the current knowledge of this next-generation market and offer a better understanding of its transportation requirements. Its findings are presented in a White Paper that offers a clearer view and a more detailed perspective on this emerging industry, identifies key logistical challenges and highlights some key points where the supply chain stakeholders could act.
Pharma.Aero enrolled on the project with its global network of over 50 Life Science logistics stakeholders and several external partners and organisations.
